Aura Biosciences, Inc. (AURA)
6.55
-0.03
(-0.46%)
USD |
NASDAQ |
Mar 20, 16:00
6.55
0.00 (0.00%)
After-Hours: 20:00
Aura Biosciences Research and Development Expense (Quarterly) : 22.18M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 0.486M |
| Olema Pharmaceuticals, Inc. | 43.22M |
| Elicio Therapeutics, Inc. | 5.031M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |